ERSTE STOCK BIOTEC EUR R01 (VTA)
AT0000673165
ERSTE STOCK BIOTEC EUR R01 (VTA)/ AT0000673165 /
NAV11/10/2024 |
Var.+2.5000 |
Type of yield |
Focus sugli investimenti |
Società d'investimento |
539.2800EUR |
+0.47% |
Full reinvestment |
Equity
Sector Biotechnology
|
Erste AM ▶ |
Investment goal
The ESPA STOCK BIOTEC fund invests in the most important biotech companies, primarily those in the USA. Equities from the Pacific region and Europe play a minor role, but are also selectively added to the fund. The currencies are not hedged against the euro. The fund is particularly suitable as an addition to an existing equity portfolio and is geared towards achieving long-term capital appreciation.
Dati master
Type of yield: |
Full reinvestment |
Fondi Categoria: |
Equity |
Paese: |
United States of America |
Settore: |
Sector Biotechnology |
Benchmark: |
Solactive United States Biotechnology Index NTR |
Business year start: |
15/03 |
Ultima distribuzione: |
12/06/2014 |
Banca depositaria: |
Erste Group Bank AG |
Domicilio del fondo: |
Austria |
Permesso di distribuzione: |
Austria, Germany, Czech Republic |
Gestore del fondo: |
Harald Kober, Tamas Menyhart |
Volume del fondo: |
223.47 mill.
EUR
|
Data di lancio: |
23/09/2002 |
Investment focus: |
- |
Condizioni
Sovrapprezzo emissione: |
4.00% |
Tassa amministrativa massima: |
1.80% |
Investimento minimo: |
0.00 EUR |
Deposit fees: |
- |
Redemption charge: |
0.00% |
Prospetto semplificato: |
Download (Print version) |
Società d'investimento
Funds company: |
Erste AM |
Indirizzo: |
Am Belvedere 1, 1100, Wien |
Paese: |
Austria |
Internet: |
www.erste-am.at
|
Paesi
United States of America |
|
79.99% |
United Kingdom |
|
9.60% |
Netherlands |
|
3.64% |
China |
|
1.08% |
Bermuda |
|
0.99% |
Denmark |
|
0.98% |
Cash |
|
0.94% |
Canada |
|
0.84% |
Virgin Islands (British) |
|
0.72% |
Ireland |
|
0.69% |
Cayman Islands |
|
0.27% |
Belgium |
|
0.16% |
Spain |
|
0.10% |
Filiali
Pharma/Biotechnology |
|
95.61% |
Healthcare services |
|
3.45% |
Cash |
|
0.94% |